Dementia Antipsychotics And Antidepressants Discontinuation Study
NCT00594269 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 149
Last updated 2011-02-23
Summary
The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).
Conditions
Interventions
- DRUG
-
Risperidone
Discontinuation
- DRUG
-
Escitalopram
Discontinuation
- DRUG
-
Citalopram
Discontinuation
- DRUG
-
Sertraline
Discontinuation
- DRUG
-
Paroxetine
Discontinuation
Sponsors & Collaborators
-
Ullevaal University Hospital
collaborator OTHER -
Eikertun Nursing Home
collaborator OTHER -
University of Bergen
collaborator OTHER -
Innlandet Hospital Trust, Sanderud
collaborator UNKNOWN -
Innlandet Hospital Trust, Reinsvoll
collaborator UNKNOWN -
Diakonhjemmet Hospital
collaborator OTHER -
Sykehuset Telemark
collaborator OTHER_GOV -
The Nordmøre and Romsdal Hospital Trust
collaborator UNKNOWN -
Songdalstunet Nursing Home
collaborator OTHER -
Sykehuset Buskerud HF
collaborator OTHER -
Kroken Nursing Home, Tromsø
collaborator OTHER -
Kløveråsen, Bodø
collaborator UNKNOWN -
Bjørgene Omsorgssenter, Haugesund
collaborator UNKNOWN -
Alesund Hospital
collaborator OTHER -
Sykehuset Innlandet HF
lead OTHER
Principal Investigators
-
Knut Engedal, Ph D · The Norwegian Centre for Dementia Research (NCDR), Norway
-
Sverre Bergh, MD · Innlandet Hospital Trust, Sanderud
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation
NCT05191277 ·Status: COMPLETED ·Phase: NA
-
Discontinuation of Antidepressant Medication in Primary Care.
NCT03361514 ·Status: COMPLETED ·Phase: NA
-
Antidepressant Discontinuation in Treatment Resistant Depression
NCT03786614 ·Status: UNKNOWN ·Phase: NA
-
Sustaining Remission of Psychotic Depression
NCT01427608 ·Status: COMPLETED ·Phase: PHASE4
-
Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms
NCT05051995 ·Status: COMPLETED ·Phase: NA
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Deprescription of Antidepressants in Primary Care (DAPriCare)
NCT06796946 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Neurobiological and Genomic Predictors of Relapse in Depression
NCT07328373 ·Status: RECRUITING
-
Repetitive Behavior Disorders in People With Severe Mental Retardation
NCT00491478 ·Status: UNKNOWN ·Phase: PHASE3
-
International Study to Predict Optimised Treatment - in Depression
NCT00693849 ·Status: UNKNOWN ·Phase: PHASE4
-
Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia
NCT01032083 ·Status: COMPLETED ·Phase: PHASE4
-
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
NCT00169988 ·Status: COMPLETED ·Phase: NA
-
The Depression in Alzheimer's Disease Study (DIADS)
NCT00009191 ·Status: COMPLETED ·Phase: PHASE4
-
Interpersonal Psychotherapy for Treatment Resistant Depression
NCT01896349 ·Status: UNKNOWN ·Phase: NA
-
Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
NCT01488266 ·Status: UNKNOWN ·Phase: NA
-
Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression
NCT00873795 ·Status: COMPLETED ·Phase: NA
-
Aripiprazole for the Augmentation of Antidepressant Therapy
NCT01429831 ·Status: COMPLETED ·Phase: PHASE4
-
Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
NCT00928980 ·Status: COMPLETED ·Phase: NA
-
Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression
NCT05063604 ·Status: TERMINATED ·Phase: PHASE2
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Sertraline on Brain Connectivity in Adolescents With OCD
NCT02797808 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tapering Off Antidepressants
NCT02661828 ·Status: TERMINATED ·Phase: NA
-
Mineralocorticoid Receptor in the Treatment of Severe Depression
NCT00295347 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects
NCT03907215 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Depression Interventions After Acute Coronary Syndrome
NCT01032018 ·Status: COMPLETED ·Phase: PHASE1/PHASE2